临床药师参与肾衰竭患者连续静脉-静脉血液滤过治疗下抗感染药个体化给药的药学监护

目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1 g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20μg/ml内;CVVH治疗期间增大美罗培南的用量为1 g、每8 h给药1次,延长每次滴注时间至3 h。结果:万古霉素首次血药浓度监测结果为22.14μg/ml,根据Ritschel一点法调整万古霉...

Full description

Saved in:
Bibliographic Details
Published in中国医院用药评价与分析 Vol. 16; no. 5; pp. 708 - 711
Main Author 彭怀东 何秋毅 陈杰 黄凯鹏 王若伦
Format Journal Article
LanguageChinese
Published 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080 2016
Subjects
Online AccessGet full text
ISSN1672-2124
DOI10.14009/j.issn.1672-2124.2016.05.049

Cover

Abstract 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1 g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20μg/ml内;CVVH治疗期间增大美罗培南的用量为1 g、每8 h给药1次,延长每次滴注时间至3 h。结果:万古霉素首次血药浓度监测结果为22.14μg/ml,根据Ritschel一点法调整万古霉素给药方案为0.4 g、每12 h给药1次,再次监测谷浓度为18.05μg/ml。临床药师通过治疗药物监测和个体化剂量调整保证了抗感染药治疗的有效性与安全性,促使患者的病情好转。结论:临床药师参与临床药物治疗,可对此类特殊患者开展药学服务,制订个体化抗感染给药方案,发挥在药物治疗中的作用。
AbstractList 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1 g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20μg/ml内;CVVH治疗期间增大美罗培南的用量为1 g、每8 h给药1次,延长每次滴注时间至3 h。结果:万古霉素首次血药浓度监测结果为22.14μg/ml,根据Ritschel一点法调整万古霉素给药方案为0.4 g、每12 h给药1次,再次监测谷浓度为18.05μg/ml。临床药师通过治疗药物监测和个体化剂量调整保证了抗感染药治疗的有效性与安全性,促使患者的病情好转。结论:临床药师参与临床药物治疗,可对此类特殊患者开展药学服务,制订个体化抗感染给药方案,发挥在药物治疗中的作用。
R969.3; 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践.方法:介绍临床药师参与会诊的1例肾衰竭合并肺部感染患者行CVVH治疗,临床药师建议万古霉素首剂给予1g,维持剂量0.5 g/次、每12 h给药1次,达到稳态后监测血药谷浓度,根据监测结果调整万古霉素给药方案,使其谷浓度控制在15~20 μg/ml内;CVVH治疗期间增大美罗培南的用量为1g、每8h给药1次,延长每次滴注时间至3h.结果:万古霉素首次血药浓度监测结果为22.14 μg/ml,根据Ritschel 一点法调整万古霉素给药方案为0.4 g、每12 h给药1次,再次监测谷浓度为18.05 μg/ml.临床药师通过治疗药物监测和个体化剂量调整保证了抗感染药治疗的有效性与安全性,促使患者的病情好转.结论:临床药师参与临床药物治疗,可对此类特殊患者开展药学服务,制订个体化抗感染给药方案,发挥在药物治疗中的作用.
Author 彭怀东 何秋毅 陈杰 黄凯鹏 王若伦
AuthorAffiliation 广州医科大学附属第二医院药学部,广东广州510260 中山大学附属第一医院药学部,广东广州510080
AuthorAffiliation_xml – name: 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080
Author_FL PENG Huaidong
HUANG Kaipeng
WANG Ruolun
CHEN Jie
HE Qiuyi
Author_FL_xml – sequence: 1
  fullname: PENG Huaidong
– sequence: 2
  fullname: HE Qiuyi
– sequence: 3
  fullname: CHEN Jie
– sequence: 4
  fullname: HUANG Kaipeng
– sequence: 5
  fullname: WANG Ruolun
Author_xml – sequence: 1
  fullname: 彭怀东 何秋毅 陈杰 黄凯鹏 王若伦
BookMark eNo9UEtLAlEYvQuDzPwTQbtmuq95LUN6gdDGvVznYSM1mkOUrUSMyl6EoFiUSNKikEIihqT8M_PqXzRi9G0O3-E84MyBmFW0dAAWEeQRhVBZLvCmbVs8EiXMYYQpjyESeSjwkCoxEP_nZ0HSts0cxIIEMSY0DmzXefc-G-Hlq-ecetc117kKa99h7y14Gfi1x7B6HI4fgtHg574T1s-4KYS9qv8x9Ef9cHziD0dBq-06536j7de7frcZZbnOs_vV9C5awagTvcFtfVIweArubvxGfx7MGGzH1pN_mACZtdVMaoNLb61vplbSnCpShdOggDSFEaIxVZExJCoWZMQEHUNJNFQEDY0pTEeUUFlQKVIglAysGlqO6BEhkQRYmsYeMMtgVj5bKO6Xragwe5SvRFcqVIzDyVBQiGaK5AtTubpdtPJ7ZmQolc1dVq5kRVFBMoGUkl94fpfc
ClassificationCodes R969.3
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.14009/j.issn.1672-2124.2016.05.049
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Pharmaceutical Practice of Clinical Pharmacists in Individual Anti-infection Treatment for Renal Failure Patient with Continuous Veno-venous Hemofiltration
DocumentTitle_FL Pharmaceutical Practice of Clinical Pharmacists in Individual Anti-infection Treatment for Renal Failure Patient with Continuous Veno-venous Hemofiltration
EndPage 711
ExternalDocumentID zgyyyypjyfx201605049
669183044
GrantInformation_xml – fundername: 广东省医院药学研究基金
  funderid: (2016A30)
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
ABDBF
ACUHS
EOJEC
OBODZ
PSX
TCJ
TUS
ID FETCH-LOGICAL-c649-d051d9a33dac98203c2581a5e2076fc10fda9ae143485c419007f2cfdb3e85c73
ISSN 1672-2124
IngestDate Thu May 29 04:11:27 EDT 2025
Wed Feb 14 10:18:30 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords 临床药师
万古霉素
连续静脉-静脉血液滤过
Continuous veno-venous hemofiltration
Vancomycin
个体化给药
Individualized dosage regimen
Clinical pharmacists
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c649-d051d9a33dac98203c2581a5e2076fc10fda9ae143485c419007f2cfdb3e85c73
Notes OBJECTIVE: To investigate the pharmaceutical practice of clinical pharmacists in formulating the individualized dosage regimen of anti-infective drugs for a renal failure patient with continuous veno-venous hemofiltration( CVVH). METHODS: A case of lung infection combined with renal failure undergoing CVVH therapy was reported.Clinical pharmacists recommended a loading dose of 1 g of vancomycin,followed by a maintenance dose of 0. 5 g q 12 h.Therapeutic drug monitoring was taken after plasma concentration reached steady value,the administration scheme of vancomycin was adjusted according to the monitoring results,and the trough concentration was controlled within 15-20 μg / ml. During the treatment of CVVH,the dosage of meropenem had been increased to 1 g q 8h,and the infusion time had been prolonged to 3 h. RESULTS: The first monitoring result of plasma concentration of vancomycin was 22. 14 μg / ml;according to the Ritschel one-point method,clinical pharmacists decreased vancomycin dose to 0. 4 g q12 h,and
PageCount 4
ParticipantIDs wanfang_journals_zgyyyypjyfx201605049
chongqing_primary_669183044
PublicationCentury 2000
PublicationDate 2016
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – year: 2016
  text: 2016
PublicationDecade 2010
PublicationTitle 中国医院用药评价与分析
PublicationTitleAlternate Evaluation and Analysis of Drug-use in Hospitals of China
PublicationTitle_FL Evaluation and Analysis of Drug-Use in Hospitals of China
PublicationYear 2016
Publisher 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080
Publisher_xml – name: 广州医科大学附属第二医院药学部,广东广州,510260%中山大学附属第一医院药学部,广东广州,510080
SSID ssib025702234
ssib017477209
ssib001103637
ssib051368574
ssib000405437
ssib001215202
ssib036441963
ssib006563103
ssib057928707
Score 2.047707
Snippet 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践。方法:介绍临床药师参与会诊的1例肾衰...
R969.3; 目的:探讨临床药师参与肾衰竭患者连续静脉-静脉血液滤过(continuous veno-venous hemofiltration,CVVH)期间抗感染治疗的药学实践.方法:介绍临床药师参与会诊的1例...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 708
SubjectTerms 万古霉素
个体化给药
临床药师
连续静脉-静脉血液滤过
Title 临床药师参与肾衰竭患者连续静脉-静脉血液滤过治疗下抗感染药个体化给药的药学监护
URI http://lib.cqvip.com/qk/86765X/201605/669183044.html
https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201605049
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVCAB
  databaseName: Nutrition and Food Sciences Database
  issn: 1672-2124
  databaseCode: DYU
  dateStart: 20150101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.cabidigitallibrary.org/product/zd
  omitProxy: true
  ssIdentifier: ssib001215202
  providerName: CAB International
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate - eBooks
  issn: 1672-2124
  databaseCode: ABDBF
  dateStart: 20151101
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssib057928707
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Na9RAFA_9APEiioq1Wnpwjqn5mmTmONlkKYKeWqinssluWjxsq23B9lRKRa1fSKGlipZi8aAUpYgsLtp_Zr_8L3xvkt2d2iJVcFmyL5Nf3uckeS-bzGjaNebEHlx3Iz2JLFuHIzHRGTOp7hUYjyKjSGP5NOHNW-7ouHNjgk709LvKU0sL89FIvHTseyX_ElVog7jiW7J_EdkOU2gAGuILS4gwLE8UYxI6xGfEd0hIiS8IEyRkhAVE5GUL0AwJlifMysAslBiL-JIQJvENEnpE-EQEJHRxk7AlxiCMIuHnCQ8R46cYTnhAOJcYSEW5frQpYw0sgKMPX0sSsL-TcWSebLGwEVhzl3CvraIv9RCyxUWGPI8ELLmtWCjBQkgikJvA1ByySnXN9EnBIEIgK9VBYIyQYA5gMxMqHDVhb0sJEA8wP8ikoNocRQhLcnCIYApzhksU5yDS9xTvU4wKc6VFIeGd_4tkyIJ2FAzpPLkTz3UhqalURszLPIWSaBcitcLAuxgU31C3gC5M9hZwP6oJLYDNq_d-0pdS5XEqNeIYLSQ82Qs6xksF0GsUgwp016GpBmmvNLO-I3L4Rf0FcjjGiUcDA0xsdKuVUzTJXHKMblYOTv1QOROLHgob6OD_g57yCPhvehrp1GJZQuB6lg7pnXMoY3CVMyNVLv-ewZRM0kvTiCNJClw2ucxSUMJIRwI-Z-rKYYTTQXx_Gwd-aWoRPrN3FpP7CDQowHq1fsuDDLtP6xd-4OeVQg1KMaXwgCTfdtV1nM5aGfgPqjqccLC9bnoOVN3dgf1srJp4d6A-auK8Fd3CkXocH5iQM1m1zTmlkbax1_9kKg5qMz1TnroLqbp8c7KcFMpTSpI_dlY7k1XnwyI91Z7Tepamz2tztcqX-re11rNP9cqj-ouVWuV5a-VHa-dz8-NeY-Vda_lB6-Bts7r3881Wa_Wxnv60dpYbX_cb1d3WwcPGfrW5sVmrPGmsbTZWtxvb68CrVvlQ-75ef7rRrG7BavPVKgrYe998_bKxtntBG8uHY7lRPZurRo9dh-tFcEmRF2y7WIg5FFV2bFFmFmjJMjw3iU0jKeI0CFCcOozG4EsozRIrToqRXYIGz76o9ZVnyqVL2nDklmIngr0Y3qormAVesiPHLCRFKyrGsTWgDXb8NTmbDkk06boccjPDcQY0knlwMrtQzU0e13MunxA3qJ1GOr3pfEXrm7-3ULoKZdh8NJT1uSGtN7g9_gurfDHe
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E4%B8%B4%E5%BA%8A%E8%8D%AF%E5%B8%88%E5%8F%82%E4%B8%8E%E8%82%BE%E8%A1%B0%E7%AB%AD%E6%82%A3%E8%80%85%E8%BF%9E%E7%BB%AD%E9%9D%99%E8%84%89-%E9%9D%99%E8%84%89%E8%A1%80%E6%B6%B2%E6%BB%A4%E8%BF%87%E6%B2%BB%E7%96%97%E4%B8%8B%E6%8A%97%E6%84%9F%E6%9F%93%E8%8D%AF%E4%B8%AA%E4%BD%93%E5%8C%96%E7%BB%99%E8%8D%AF%E7%9A%84%E8%8D%AF%E5%AD%A6%E7%9B%91%E6%8A%A4&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E5%BD%AD%E6%80%80%E4%B8%9C&rft.au=%E4%BD%95%E7%A7%8B%E6%AF%85&rft.au=%E9%99%88%E6%9D%B0&rft.au=%E9%BB%84%E5%87%AF%E9%B9%8F&rft.date=2016&rft.pub=%E5%B9%BF%E5%B7%9E%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%BA%8C%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%B9%BF%E4%B8%9C%E5%B9%BF%E5%B7%9E%2C510260%25%E4%B8%AD%E5%B1%B1%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%B9%BF%E4%B8%9C%E5%B9%BF%E5%B7%9E%2C510080&rft.issn=1672-2124&rft.volume=16&rft.issue=5&rft.spage=708&rft.epage=711&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2016.05.049&rft.externalDocID=zgyyyypjyfx201605049
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg